$1.25 stock on next positive SAS results (de-risks clinical trial further), $2-$2.50 on Phase II trial success, $5-10 on licensing deal. On the flipside, cash backing of $0.05 on Phase II failure.
Downside only limited to what I'm willing to lose, upside will pay for a nice little vacation home. I'll take those odds any day. Not taking a single share out of my holdings until the outcome is final. Will be a fruitful ride (I hope). All IMO.
$1.25 stock on next positive SAS results (de-risks clinical...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.055(20.4%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 33.5¢ | 27.5¢ | $1.328M | 4.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 152597 | 4 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
